How better drugs could change kala-azar control. Lessons from a cost-effectiveness analysis

Tropical Medicine and International Health

Volumn 7, Issue 11, 2002, Pages 955-959

  Boelaert, M ^a   Le Ray, D ^a   Van der Stuyft, P ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

Cost effectiveness analysis; Drug treatment; Visceral leishmaniasis

Indexed keywords

ANTIPROTOZOAL AGENT; MEGLUMINE ANTIMONATE; STIBOGLUCONATE SODIUM;

COST; DISEASE CONTROL; DRUG PRESCRIBING; LEISHMANIASIS;

ANTIMICROBIAL THERAPY; ARTICLE; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; DRUG SAFETY; HEALTH CARE COST; MEDICAL DECISION MAKING; PARASITE CONTROL; PARASITE IDENTIFICATION; SERODIAGNOSIS; VISCERAL LEISHMANIASIS;

AGGLUTINATION TESTS; ALGORITHMS; ANTIPROTOZOAL AGENTS; COST-BENEFIT ANALYSIS; DECISION TREES; DRUG DESIGN; HUMANS; LEISHMANIASIS, VISCERAL; SENSITIVITY AND SPECIFICITY;

NASO HEXACANTHUS; PROTOZOA;

EID: 0036434128     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3156.2002.00959.x     Document Type: Article

References (16)

1. Addy M & Nandy A (1992) Ten years of kala-azar in West Bengal, Part I. Did post-kala-azar dermal leishmaniasis initiate the outbreak in 24-Parganas? Bulletin of the World Health Organization 70, 341-346.
2. Alvar J, Canavate C, Gutierrez-Solar B et al. (1997) Leishmania and human immunodeficiency virus coinfection: The first 10 years. Clinical Microbiology Reviews 10, 298-319.
3. Ballou WR, McClain JB, Gordon DM et al. (1987) Safety and efficacy of high-dose sodium stibogluconate therapy of American cutaneous leishmaniasis. Lancet ii, 13-16.
4. Boelaert M, Criel B, Leeuwenburg J, Van Damme W, Le Ray D & Van der Stuyft P (2000) Visceral leishmaniasis control, a public health perspective. Transactions of the Royal Society of Tropical Medicine and Hygiene 94, 465-471.
5. Boelaert M, El Safi S, Mousa H et al. (1999a) Multi-centre evaluation of repeatability and reproducibility of the direct agglutination test for visceral leishmaniasis. Tropical Medicine and International Health 4, 31-37.
6. Boelaert M, Lynen L, Desjeux P & Van der Stuyft P (1999b) Cost-effectiveness of competing diagnostic-therapeutic strategies for visceral leishmaniasis. Bulletin of the World Health Organization 77, 667-674.
7. El Harith A, Kolk AH, Kager PA et al. (1986) A simple and economical direct agglutination test for serodiagnosis and sero-epidemiological studies of visceral leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene 80, 583-587.
8. Elnaiem DA, Elnahas AM & Aboud MA (1999) Protective efficacy of lambdacyhalothrin-impregnated bednets against Phlebotomus orientalis, the vector of visceral leishmaniasis in Sudan. Medical Veterinary Entomology 13, 310-314.
9. Griekspoor A, Sondorp E & Vos T (1999) Cost-effectiveness analysis in humanitarian relief: VL treatment in the Sudan. Health Policy and Planning 14, 70-76.
10. Herwaldt BL & Berman JD (1992) Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. American Journal of Tropical Medicine and Hygiene 46, 296-306.
11. Jha TK, Sundar S, Thakur CP et al. (1999) Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis. New England Journal of Medicine 341, 1795-1800.
12. Marsden PD (1986) Mucosal leishmaniasis ('espundia' Escomel, 1911). Transactions of the Royal Society of Tropical Medicine and Hygiene 80, 859-876.
13. Sundar S (1997) Treatment of visceral leishmaniasis - Current status. Journal of the Association of Physicians in India 45, 640-645.
14. Sundar S, Singh VP, Sharma S, Makharia MK & Murray HW (1997) Response to interferon-gamma plus pentavalent antimony in Indian visceral leishmaniasis. Journal of Infectious Diseases 176, 1117-1119.
15. Thakur CP, Sinha GP, Pandey AK et al. (1998) Do the diminishing efficacy and increasing toxicity of sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar, India, justify its continued use as a first-line drug? An observational study of 80 cases. Annals of Tropical Medicine and Parasitology 92, 561-569.
16. Veeken H, Ritmeijer K, Seaman J & Davidson RN (2000) A randomized comparison of branded sodium stibogluconate and generic sodium stibogluconate for the treatment of visceral leishmaniasis under field conditions in Sudan. Tropical Medicine and International Health 5, 312-317.